Anxiety disorders: Guidelines for effective primary care, part 2, treatment

Consultant

Volumn 49, Issue 4, 2009, Pages

  Khouzam, Hani Raoul ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; CHLORDIAZEPOXIDE; CITALOPRAM; CLOMIPRAMINE; CLONAZEPAM; CLONIDINE; DIAZEPAM; DIPHENHYDRAMINE; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; FLUVOXAMINE MALEATE; GUANFACINE; HYDROXYZINE; HYDROXYZINE EMBONATE; IMIPRAMINE; LORAZEPAM; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; PAROXETINE; PHENELZINE; PRAZOSIN; PROPRANOLOL; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ANXIETY DISORDER; BEHAVIOR THERAPY; COGNITIVE THERAPY; COMORBIDITY; CONSULTATION; DRUG DEPENDENCE; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; NORADRENALIN UPTAKE; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; SEXUAL DYSFUNCTION; SPIRITUAL HEALING; SUBSTANCE ABUSE;

EID: 77952902734     PISSN: 00107069     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Sadock BJ, Sadock VA. Kaplan and Sadocks Synopsis of Psychiatry: Behavioral Sciences/Clinical Psychiatry. 9th ed. Philadelphia: Lippincott Williams & Wilkins; 2007.
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
3. Gabbard GO. Treatments of Psychiatric Disorders. 3rd ed. Vols 1 & 2. Washington, DC: American Psychiatric Publishing; 2001.
4. Kendrick T. Depression in adults: GPs are not so bad at diagnosis. BMJ. 2008;336:522.
5. Khouzam HR. Depression: guidelines for effective primary care, part 1, diagnosis. Consultant. 2007;47:757-764. (Pubitemid 47185553)
6. Khouzam HR. Depression: guidelines for effective primary care, part 2, treatment. Consultant. 2007;47:841-848. (Pubitemid 350194335)
7. Kroenke K, Spitzer RL, Williams JB, et al. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007;146:317-325. (Pubitemid 351650592)
8. Cottraux J, Note I, Yao SN, et al. Randomized controlled comparison of cognitive behavior therapy with Rogerian supportive therapy in chronic posttraumatic stress disorder: a 2-year follow-up. Psychother Psychosom. 2008;77:101-110. (Pubitemid 351172100)
9. Bodden DH, Dirksen CD, Bögels SM, et al. Costs and cost-effectiveness of family CBT versus individual CBT in clinically anxious children. Clin Child Psychol Psychiatry. 2008;13:543-564.
10. Baetz M, Griffin R, Bowen R, Marcoux G. Spirituality and psychiatry in Canada: psychiatric practice compared with patient expectations. Can J Psychiatry. 2004;49:265-271. (Pubitemid 38608015)
11. Lépine JP. The epidemiology of anxiety disorders: prevalence and societal costs. J Clin Psychiatry. 2002;63(suppl 14):4-8. (Pubitemid 36013434)
12. American Psychiatric Association. Practice Guideline for the Treatment of Patients with Panic Disorder. Washington, DC: American Psychiatric Association; 1998.
13. Akpafflong MJ, Wilson-Lawson M, Kunik ME. Antidepressant-associated side effects in older adult depressed patients. Geriatrics. 2008;63:18-23. (Pubitemid 351643215)
14. Bourin M, Lambert O. Pharmacotherapy of anxious disorders. Hum Psychopharmacol. 2002;17: 383-400.
15. Otto MW, Pollack MH, Gould RA, et al. A comparison of the efficacy of clonazepam and cognitivebehavioral group therapy for the treatment of social phobia. J Anxiety Disord. 2000;14:345-358.